참고문헌
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424 https://doi.org/10.3322/caac.21492
- Mokdad AA, Lopez AD, Shahraz S et al (2014) Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 12, 145 https://doi.org/10.1186/s12916-014-0145-y
- Eastman RT and Fidock DA (2009) Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7, 864-874 https://doi.org/10.1038/nrmicro2239
- Tong Y, Liu Y, Zheng H et al (2016) Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/beta-catenin signaling. Oncotarget 7, 31413-31428 https://doi.org/10.18632/oncotarget.8920
- Ontikatze T, Rudner J, Handrick R, Belka C and Jendrossek V (2014) Dihydroartemisinin is a hypoxia-active anti-cancer drug in colorectal carcinoma cells. Front Oncol 4, 116 https://doi.org/10.3389/fonc.2014.00116
- Li Y, Wang Y, Kong R et al (2016) Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network. Oncotarget 7, 62460-62473 https://doi.org/10.18632/oncotarget.11517
- Liao K, Li J and Wang Z (2014) Dihydroartemisinin inhibits cell proliferation via AKT/GSK3beta/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells. Int J Clin Exp Pathol 7, 8684-8691
- Zhang S, Shi L, Ma H et al (2017) Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1/2 and p38 MAPK signaling pathways. J Recept Signal Transduct Res 37, 174-180 https://doi.org/10.1080/10799893.2016.1203942
- Thongchot S, Vidoni C, Ferraresi A et al (2018) Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway. Mol Carcinog 57, 1735-1750 https://doi.org/10.1002/mc.22893
- Shi X, Wang L, Li X et al (2017) Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand breakmediated oxidative stress. Oncotarget 8, 45981-45993 https://doi.org/10.18632/oncotarget.17520
- Amaravadi R, Kimmelman AC and White E (2016) Recent insights into the function of autophagy in cancer. Genes Dev 30, 1913-1930 https://doi.org/10.1101/gad.287524.116
- Acosta JC and Gil J (2012) Senescence: a new weapon for cancer therapy. Trends Cell Biol 22, 211-219 https://doi.org/10.1016/j.tcb.2011.11.006
- Itahana K, Campisi J and Dimri GP (2004) Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5, 1-10 https://doi.org/10.1023/B:BGEN.0000017682.96395.10
- Chang BD, Xuan Y, Broude EV et al (1999) Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18, 4808-4818 https://doi.org/10.1038/sj.onc.1203078
- Zhang Z, Yao Z, Zhao S et al (2017) Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis. Cell Death Dis 8, e2886 https://doi.org/10.1038/cddis.2017.255
- Wang SY, Yu QJ, Zhang RD and Liu B (2011) Core signaling pathways of survival/death in autophagy-related cancer networks. Int J Biochem Cell Biol 43, 1263-1266 https://doi.org/10.1016/j.biocel.2011.05.010
- Gao X, Luo Z, Xiang T, Wang K, Li J and Wang P (2011) Dihydroartemisinin induces endoplasmic reticulum stressmediated apoptosis in HepG2 human hepatoma cells. Tumori 97, 771-780 https://doi.org/10.1177/030089161109700615
- Im E, Yeo C, Lee HJ and Lee EO (2018) Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells. Life Sci 192, 286-292 https://doi.org/10.1016/j.lfs.2017.11.008
- Qin G, Zhao C, Zhang L et al (2015) Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells. Apoptosis 20, 1072-1086 https://doi.org/10.1007/s10495-015-1132-2
- Zhang CZ, Zhang H, Yun J, Chen GG and Lai PB (2012) Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol 83, 1278-1289 https://doi.org/10.1016/j.bcp.2012.02.002
- Sun P, Yoshizuka N, New L et al (2007) PRAK is essential for ras-induced senescence and tumor suppression. Cell 128, 295-308 https://doi.org/10.1016/j.cell.2006.11.050
- Guo X, Deng Y, Lin Y et al (2007) Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J 26, 4709-4719 https://doi.org/10.1038/sj.emboj.7601893
- Liu X, Wu J, Fan M et al (2018) Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells. Cell Death Dis 9, 1048 https://doi.org/10.1038/s41419-018-1006-y
- Qu C, Ma J, Liu X et al (2017) Dihydroartemisinin exerts anti-tumor activity by inducing mitochondrion and endoplasmic reticulum apoptosis and autophagic cell death in human glioblastoma cells. Mol Carcinog 11, 310
- Chen C, Gu P and Wu J (2017) Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer. Nat Commun 8, 14929 https://doi.org/10.1038/ncomms14929
- Kocak H, Ballew BJ, Bisht K et al (2014) Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev 28, 2090-2102 https://doi.org/10.1101/gad.248567.114